Building upon the success of 2018’s Interim Workshop on Cancer Immune Responsiveness (CIR), the goal of this year’s CIR workshop is the continued advancement of knowledge in the field about interactions between the immune system and cancer that contribute to immunotherapy response and resistance.
Over this two-day workshop, participants will take part in both didactic sessions and working groups to identify and address key questions in the field concerning cancer immune responsiveness.
Topics to be discussed include:
Enduring materials from this program are available to the general public. Please click here to access presentations to the program.
Presentations and video recordings are available based on permission from presenters.
Josue Samayoa, PhDAbbVie
Stefanie Spranger, PhDKoch Institute for Integrative Cancer Research at MIT
For those of you in the Philadelphia area, CAR-T and The Rise of the Cellicon Valley Thursday, May 9 and Friday, May 10, 2019 World experts in CAR T-cellular therapy and hematopoietic stem cell transplantation (HSCT) have been assembled to ...
This message was posted by a user wishing to remain anonymous The 8th Conference of IAOC "Current Status and Future of Anti-Cancer Therapies" will be held in Buenos Aires, Argentina in October 17th and 18th, 2019. An outstanding faculty of speakers ...
Clinical Application of CAR T Cells
March 14-15, 2019 | New York, NY REGISTER NOW! Space is limited and this course will likely sell out. Current registrants include attendees from over 30 companies and 50 academic institutions . Register ...
Hello Anyone can share their experience with sarcoidosis flare after treatment with a PD-1 inhibitor? Thank you ------------------------------ Priscila Goncalves Associate Director Center for Novel Cancer Therapies Northwell Health - Monter Cancer Center ...
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org